Therefore, we employed CD49f, together with Trop2 as a pan‐epithelial marker, as a CSC enrichment marker to separate tumor cells into matched CSC‐enriched population (CD49fhiTrop2+) and non‐CSC population (CD49f−/loTrop2+). This evidence concerns the gene TACSTD2 and neoplasm.